Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strengthening Transplantation Effects of Bone Marrow Mononuclear Cells With Atorvastatin in Myocardial Infarction
NCT00979758Phase 2Completed
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jan 2009
- Primary completion
- Jun 2015
- Modality
- Stem Cell Therapies, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin, autologous bone marrow-derived mononuclear cell in myocardial infarction (MI), sponsored by Chinese Academy of Medical Sciences. Started Jan 2009; status: completed.
02
Drugs
atorvastatinautologous bone marrow-derived mononuclear cell
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00979758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00979758.